Avita Medical | 1811094D - 資産



金融部門
株価
AUD
資産
AUD 56.39M
現金と同等
AUD 10.24M
売上原価
AUD 3.3M
流動資産
AUD 35.49M
流動負債
AUD 62.68M
負債
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
従業員
AUD 87
株当たりのEPS利益
AUD -0.38
自己資本および準備金
AUD -16.65M
売上総利益
AUD 14.31M
債務の支払利息
AUD 1.25M
借入資本
AUD 42.25M
時価総額
AUD 280.47M
当期純利益
AUD -11.62M
営業経費
AUD 28.02M
営業利益
AUD -10.41M
税引前利益
AUD -11.64M
販売収入
AUD 17.62M
販売および管理費
AUD 19.03M
株式
AUD 6.93M
貿易債権者
AUD 8.96M
貿易債務者
AUD 9.11M


資産 変化する 日付
Accuray USD 448.01M 8.81M 2025-12
Celltrion KRW 768.81B 9.37B 2026-03
Clinuvel Pharmaceuticals AUD 269.7M 2.05M 2025-12
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.21B 33.61M 2026-06
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Mayne Pharma AUD 1.14B 9.47M 2024-06
Medical Developments International AUD 63.57M 2.83M 2025-12
Nanosonics AUD 279.25M 6.77M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 521.31M 9.36M 2026-03
Ovoca Bio EUR 2.07M 414K 2025-12
Pacific Edge NZD 17.6M 17.06M 2026-06
Paradigm Biopharmaceuticals AUD 23.15M 1.42M 2025-12
Pharma Mar EUR 393.6M 8.34M 2026-06
Polynovo AUD 123.37M 4.04M 2025-12
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Qiagen NV USD 5.89B 107.14M 2026-06
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.78B 280.91M 2026-03
Sartorius EUR 9.6B 270.6M 2026-06
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Telix Pharmaceuticals AUD 1.16B 25.97M 2025-12
Tilray USD 2.1B 15.95M 2025-09
Zealand Pharma A/S 15.3B 647.8M 2026-03
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03